Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.568ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.568EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.568EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.568ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.568ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.13 (Gamma)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.1.13 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.13 (Gamma)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
P.1.13 (Gamma)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
P.1.13 (Gamma)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.1.13 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.13 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.13 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.372EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.372EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.372ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.372ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.372EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.372EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.372ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.372ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.634EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.634EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.634ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.634ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.634EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.634EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.634ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.634ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.37.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.37.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.37.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.37.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.37.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.37.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.37.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.37.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.630EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.630EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.630ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.630ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.630EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.630EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.630ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.630ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.360EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.360EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.360ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.360ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.360EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used